VRTX Vertex Pharmaceuticals
$502.31 -0.24%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.24%
YTD
+22.40%
P/E
30.08
P/B
6.16
ROE
23.3%
Div yield
—
Beta
0.5
Market cap
$132.5B
RSI (14)
38
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$505.00
Close
$502.31
VWAP (n/a)
—
Day high
$507.41
Day low
$496.33
Volume
775K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance · Oct 5
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Yahoo Finance · Oct 4
Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets
Yahoo Finance · Oct 3
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks
Yahoo Finance · Oct 1
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo Finance · Oct 1
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Yahoo Finance · Oct 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 1, 2026 View → 10-Q Aug 4, 2026 View → 8-K Aug 3, 2026 View → 8-K Jul 7, 2026 View → 8-K May 13, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VRTX. Try it in the Lab to size a position and see the risk.